Breaking News

Novartis pays $100M to get Mallinckrodt’s ticket for a speedier FDA drug review

Not rendering correctly? View this email as a web page here.

MedCity News will be observing the Fourth of July on Monday. The next newsletter will be sent out on Tuesday, July 5.

As M&A costs rise, new Accenture report offers alternative strategies

By Joel Berg Friday, July 1, 2022 12:58 PM

Rising deal premiums and shrinking profit margins are threatening the sustainability of the traditional approach to mergers and acqusitions, according to a report by Accenture. The firm expects growth-minded companies will turn to other pathways.

Read more »

Nearly half of providers are behind on revenue goals amid RCM department labor shortages, report shows

By Katie Adams Friday, July 1, 2022 12:55 PM

Nearly half of health systems and physician groups in the U.S. are behind on their 2022 revenue goals, and healthcare executives are worried about increasing costs, shrinking margins and the impending recession, according to a new report. It also found that most healthcare organizations' revenue cycle or billing departments are struggling with labor shortages, leading operational inefficiencies and negative patient billing experiences.

Read more »

   

No comments